<DOC>
	<DOCNO>NCT01969227</DOCNO>
	<brief_summary>Maintaining patency upper airway sedate anesthetized patient challenge especially patient ready wean mechanical ventilation . Impairment airway patency common cause extubation failure opioids hypnotic adversely affect airway patency . Ketamine , noncompetitive antagonist N-methyl-D- aspartate ( NMDA ) , unlike anesthetic activates respiratory effort promote bronchodilation . At subanesthetic plasma concentration , ketamine reduces opioid propofol requirement . Recent animal data suggest add propofol sedation regimen , ketamine decrease hypoventilation compare propofol alone ketamine increase genioglossus phasic activity abolish couple loss consciousness upper airway dilator muscle activity . However , relationship examine human combination drug . The purpose pharmaco-physiological interaction trial evaluate effect ketamine breathe electroencephalography mechanical ventilate patient . Spirometry utilized evaluate upper airway patency . Polysomnography ( PSG- Alice PDx ) use evaluate effect ketamine EEG wakefulness sleep . An esophageal balloon inserted measure esophageal pressure , enable u measure effect ketamine transpulmonary pressure . A volumetric capnography , NICO noninvasive device Respironics use measure anatomical dead space , CO2 production , mean expiratory CO2 slope alveolar plateau volumetric capnogram</brief_summary>
	<brief_title>The Effects Ketamine Respiratory Stimulation Transpulmonary Pressures</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<criteria>Age â‰¥ 18 year admit ICU require mechanical ventilation Suitable spontaneous breathe trial Candidate receive low dose ketamine primary critical care team Esophageal injury Allergic ketamine Known neurodegenerative disorder Major neurologic disorder ( elevate ICP )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>